TickerGuard
Buy Day today: Good (67) Broad market participation · no major macro event

Hims Hers Health Inc (HIMS)

Healthcare Drug Manufacturers - Specialty & Generic
30.80 $
+11.0% vs. previous close
Closing price · As of: 3. Aug 2026

Hims Hers Health Inc (HIMS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Revenue" came in at 608 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Income Statement HIMS
Tick rows to compare them in a chart (up to 4) Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 LTM
208 227 247 278 316 402 481 586 545 599 618 608 2,370
38 39 43 49 59 84 112 155 129 157 173 308 767
170 187 204 229 257 318 370 431 416 442 444 300 1,603
12 12 13 15 19 21 24 30 38 41 41 47 166
31 36 32 35 41 45 48 49 67 81 76 110 334
179 196 204 219 246 296 351 373 389 430 435 317 1,572
-9.2 -8.6 -0.4 9.9 11 22 19 58 27 12 9.2 -16 31
1.6
-7.2 -6.9 2.2 12 13 24 22 60 33 12 18 -102 -38
0.0 0.7 1.0 1.3 0.1 -52 -3.7 11 -9.7 -3.6 -2.2 -9.4 -25
-7.2 -7.6 1.2 11 13 76 26 49 43 16 21 -92 -13
-4.8 -4.6 4.9 15 17 28 28 69 43 30 36 -80 30

LTM = last twelve months (sum of the four most recent quarters).

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?